About Istanbul Universitesi Kardiyoloji Enstitusu
Clinical Trials at Istanbul Universitesi Kardiyoloji Enstitusu
During the past decade, Istanbul Universitesi Kardiyoloji Enstitusu conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Istanbul Universitesi Kardiyoloji Enstitusu
According to Clinical.Site data, the most researched conditions in "Istanbul Universitesi Kardiyoloji Enstitusu" are
"Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Istanbul Universitesi Kardiyoloji Enstitusu" in a lesser frequency.
Clinical Trials Intervention Types at Istanbul Universitesi Kardiyoloji Enstitusu
Most popular intervention types in "Istanbul Universitesi Kardiyoloji Enstitusu" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istanbul Universitesi Kardiyoloji Enstitusu
The vast majority of trials in "Istanbul Universitesi Kardiyoloji Enstitusu" are
6 trials for "All" genders.
Clinical Trials Status at Istanbul Universitesi Kardiyoloji Enstitusu
Currently, there are NaN active trials in "Istanbul Universitesi Kardiyoloji Enstitusu".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Istanbul Universitesi Kardiyoloji Enstitusu,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Istanbul Universitesi Kardiyoloji Enstitusu, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".